uniQure
QURE
#5100
Rank
HK$13.35 B
Marketcap
HK$211.81
Share price
-2.52%
Change (1 day)
84.28%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2026 (TTM): -HK$1.59 Billion

According to uniQure's latest financial reports the company's current earnings are HK$18.09 Million. In 2025 the company made an earning of -HK$1.52 Billion, an increase over its 2024 earnings that were of -HK$1.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$1.59 Billion4.84%
2025 -HK$1.52 Billion-18.47%
2024 -HK$1.86 Billion-22.65%
2023 -HK$2.41 Billion139.01%
2022 -HK$1.01 Billion-138.54%
2021 HK$2.60 B-335.29%
2020 -HK$1.11 Billion13.88%
2019 -HK$0.98 Billion49.51%
2018 -HK$0.66 Billion4.55%
2017 -HK$0.63 Billion12.65%
2016 -HK$0.56 Billion-9.59%
2015 -HK$0.62 Billion66.95%
2014 -HK$0.37 Billion30.8%
2013 -HK$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$71.15 B-4,570.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$59.96 B-3,868.08%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-HK$0.86 Billion-46.36%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-HK$1.57 Billion-1.69%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.01 B-289.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-HK$5.37 Billion 236.85%๐Ÿ‡บ๐Ÿ‡ธ USA